Proactive Investors - Run By Investors For Investors

Cliintel Capital Management takes on Cannapharmarx, predicts revenues of C$25M

Cliintel Capital Management Group LLC Founding Partner Rick Batenburg III tells Proactive Investors that the private equity firm specializing in incubating cannabis companies, has taken on Canadian-based Cannapharmarx Inc (OTCMKTS:CPMD), saying the fund found the cannabis company attractive due to its ability to grow at large, industrial scale.

Batenburg says, in addition, the company has stabilized its energy cost by using an on-site power plant and using natural gas, and he expects the company to produce 110,000 kg of cannabis per year, expecting the company to pull in over C$25 million in 2019.

 
View full CLIIN profile View Profile

Cliintel Capital Management Group LLC Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use